EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy

Luis Daniel Goyzueta-Mamani iD, Daniela Pagliara Lage, Haruna Luz Barazorda-Ccahuana iD, Margot Paco-Chipana, Mayron Antonio Candia-Puma iD, Gonzalo Davila-Del-Carpio iD, Alexsandro Sobreira Galdino iD, Ricardo Andrez Machado-de-Avila iD, Rodolfo Cordeiro Giunchetti iD, Edward L D'Antonio iD, Eduardo Antonio Ferraz Coelho iD, Miguel Angel Chávez-Fumagalli iD

Molecules · 04.01.2025 · 30 (1) · 173

DOI: 10.3390/molecules30010173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 04.01.2025. Verfasst von Luis Daniel Goyzueta-Mamani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, Peru. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmania, Naphthoquinones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ProCiencia, Universidad Catolica de Santa Maria, Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis, a neglected tropical disease caused by Leishmania species, presents serious public health challenges due to limited treatment options, toxicity, high costs, and drug resistance. In this study, the in vitro potential of malvidin and echioidinin is examined as antileishmanial agents against L. amazonensis, L. braziliensis, and L. infantum, comparing their effects to amphotericin B (AmpB), a standard drug. Malvidin demonstrated greater potency than echioidinin across all parasite stages and species. Against L. amazonensis, malvidin’s IC50 values were 197.71 ± 17.20 µM (stationary amastigotes) and 258.07 ± 17 µM (axenic amastigotes), compared to echioidinin’s 272.99 ± 29.90 μM and 335.96 ± 19.35 μM. AmpB was more potent, with IC50 values of 0.06 ± 0.01 µM and 0.10 ± 0.03 µM. Malvidin exhibited lower cytotoxicity (CC50: 2920.31 ± 80.29 µM) than AmpB (1.06 ± 0.12 µM) and a favorable selectivity index. It reduced infection rates by 35.75% in L. amazonensis-infected macrophages. The in silico analysis revealed strong binding between malvidin and Leishmania arginase, with the residues HIS139 and PRO258 playing key roles. Gene expression analysis indicated malvidin’s modulation of oxidative stress and DNA repair pathways, involving genes like GLO1 and APEX1. These findings suggest malvidin’s potential as a safe, natural antileishmanial compound, warranting further in vivo studies to confirm its therapeutic efficacy and pharmacokinetics in animal models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsLeishmaniaNaphthoquinonesMolecular Docking SimulationAnimalsComputer SimulationParasitic Sensitivity TestsAmphotericin BMiceLeishmaniasisLeishmania infantumInhibitory Concentration 50

Stichwörter der Autor:innen

antileishmanial activityarginase inhibitioncytotoxicityechioidininleishmaniasismalvidin

Substanzen

Antiprotozoal AgentsAmphotericin BNaphthoquinones

Autor:innen und Institutionen

  • Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, Peru.
  • Programa de Pós-Graduação em Ciências da Saúde: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
  • Facultad de Ciencias Farmacéuticas, Bioquímicas y Biotecnológicas, Universidad Católica de Santa María, Arequipa 04000, Peru.
  • Laboratório de Biotecnologia de Microrganismos, Universidade Federal São João Del-Rei, Divinópolis 35501-296, Brazil.
  • Instituto Nacional de Ciência e Tecnologia em Biotecnologia Industrial (INCT-BI), Distrito Federal, Brasilia 70070-010, Brazil.
  • Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, Brazil.

ORCID-Profile: Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, Mayron Antonio Candia-Puma, Gonzalo Davila-Del-Carpio, Alexsandro Sobreira Galdino, Ricardo Andrez Machado-de-Avila, Rodolfo Cordeiro Giunchetti, Edward L D'Antonio, Eduardo Antonio Ferraz Coelho, Miguel Angel Chávez-Fumagalli

Förderung

  • ProCiencia
  • Universidad Catolica de Santa Maria
  • Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (CONCYTEC)
  • Universidad Católica de Santa Maria
  • Research Management Office from the Universidad Católica de Santa María
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

Goyzueta-Mamani, L. D., Pagliara Lage, D., Barazorda-Ccahuana, H. L., Paco-Chipana, M., Candia-Puma, M. A., Davila-Del-Carpio, G., Galdino, A. S., Machado-de-Avila, R. A., Cordeiro Giunchetti, R., D'Antonio, E. L., Ferraz Coelho, E. A., & Chávez-Fumagalli, M. A. (2025). Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy. Molecules, 30(1), 173. https://doi.org/10.3390/molecules30010173

Vancouver

Goyzueta-Mamani LD, Pagliara Lage D, Barazorda-Ccahuana HL, Paco-Chipana M, Candia-Puma MA, Davila-Del-Carpio G, et al. Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy. Molecules. 2025;30(1):173. doi:10.3390/molecules30010173

BibTeX
@article{GoyzuetaMamani2025,
  author = {Goyzueta-Mamani, Luis Daniel and Pagliara Lage, Daniela and Barazorda-Ccahuana, Haruna Luz and Paco-Chipana, Margot and Candia-Puma, Mayron Antonio and Davila-Del-Carpio, Gonzalo and Galdino, Alexsandro Sobreira and Machado-de-Avila, Ricardo Andrez and Cordeiro Giunchetti, Rodolfo and D'Antonio, Edward L and Ferraz Coelho, Eduardo Antonio and Chávez-Fumagalli, Miguel Angel},
  title = {Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {1},
  pages = {173},
  doi = {10.3390/molecules30010173}
}
Kostenlos starten →